Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Adicet Bio Inc (NQ: ACET ) 1.250 -0.030 (-2.34%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 246,948 Open 1.300 Bid (Size) 1.260 (3) Ask (Size) 1.270 (2) Prev. Close 1.280 Today's Range 1.250 - 1.300 52wk Range 1.050 - 3.770 Shares Outstanding 42,957,586 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Adicet Bio to Participate in Upcoming Investor Conferences November 01, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) October 31, 2024 From Adicet Bio, Inc. Via Business Wire Performance YTD -37.81% -37.81% 1 Month -11.97% -11.97% 3 Month -3.85% -3.85% 6 Month -26.04% -26.04% 1 Year -24.24% -24.24% More News Read More Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome October 16, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) September 30, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference September 30, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Opens Enrollment for ADI-001 Phase 1 Clinical Trial in Autoimmune Diseases September 30, 2024 From Adicet Bio, Inc. Via Business Wire ADI-001 Clinical Biomarker Data Demonstrate Robust Tissue Trafficking and Complete B Cell Depletion in Secondary Lymphoid Tissue September 19, 2024 From Adicet Bio, Inc. Via Business Wire This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday September 11, 2024 Via Benzinga Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 30, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference August 27, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors August 19, 2024 From Adicet Bio, Inc. Via Business Wire ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024 August 13, 2024 Via InvestorPlace Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates August 13, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio to Participate in Upcoming Investor Conferences August 01, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 31, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma July 08, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 28, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma June 24, 2024 From Adicet Bio, Inc. Via Business Wire Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 June 10, 2024 Via InvestorPlace Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis June 05, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 31, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference May 29, 2024 From Adicet Bio, Inc. Via Business Wire ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024 May 14, 2024 Via InvestorPlace Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates May 14, 2024 From Adicet Bio, Inc. Via Business Wire Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress May 14, 2024 From Adicet Bio, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
